Tuberculosis treatment is expensive for patients in developing countries

BMJ 1997; 315 doi: https://doi.org/10.1136/bmj.315.7101.187a (Published 19 July 1997) Cite this as: BMJ 1997;315:187
  1. Elizabeth Bevan, Medical officer in chargea
  1. a PCEA Tumutumu Hospital, Private Bag, Karatina, Kenya

    Editor—I was disappointed to read of the attitude of the World Health Organisation and others to the use of directly observed treatment short course (DOTS) for tuberculosis.1 Such treatment is described as a cheap and effective public health breakthrough. The failure of the method is blamed on doctors explicitly by Sir John Crofton and implicitly by the director of …

    View Full Text

    Sign in

    Log in through your institution